Status:
COMPLETED
Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
Lead Sponsor:
Medamonitor
Conditions:
Ketosis
Eligibility:
All Genders
18-65 years
Brief Summary
Subjects will provide blood and breath samples to evaluate the relationship between breath acetone and two blood-bound species: beta-hydroxybutyrate and glucose. Subjects will be asked to provide brea...
Detailed Description
The LEVL device (Medamonitor, Seattle, WA) provides users a method for assessing their own rate of fat metabolism. The LEVL device measures the concentration acetone in breath that the scientific lite...
Eligibility Criteria
Inclusion
- 1\. Subject must complete the consent process
Exclusion
- Subjects with severe lung disease which would prevent them from providing a breath sample through a large bore tube (e.g., large drinking straw)
- Subjects with diabetes (Type 1 or Type 2)
- Subjects who are routinely exposed to paints, paint thinners, gasoline, varnishes, glues, dry cleaning solvents, or industrial cleaning products
- Daily smoker of cigarettes, e-cigarettes, or marijuana
- Abstain from alcohol over the prior 24 hours
- Refrain from consumption of large amounts of garlic
Key Trial Info
Start Date :
September 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT03299543
Start Date
September 12 2017
End Date
February 28 2018
Last Update
August 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medamonitor, LLC
Seattle, Washington, United States, 98119